Reuters Pharma 2026 | Barcelona
A defining moment in my speaking journey. At Reuters Pharma 2026, I presented a keynote on uncertainty in drug development, exploring how probability, evidence, and policy are reshaping the architecture of modern regulatory decision-making.
The session brought together senior leaders across R&D, regulatory affairs, and market access—and sparked a deeply engaging dialogue on moving beyond deterministic models toward a more nuanced, probabilistic understanding of approval, value, and patient impact.
The images and videos here capture not just a talk, but the beginning of a broader conversation—one that I intend to carry forward across global forums in the years ahead
